Risk factors for renal disease in systemic lupus erythematosus and their clinical implications

References

• Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet 2014;384(9957):1878-88
   PubMed Web of Science ®Google Scholar
• Chan TM. Treatment of severe lupus nephritis: the new horizon. Nat Rev Nephrol 2015;11(1):46-61
   PubMed Web of Science ®Google Scholar
• Jayne D, Jones R. Lupus nephropathy and vasculitis. Medicine (Baltimore) 2007;35(9):516-20
   Google Scholar
• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358(9):929-39
   PubMed Web of Science ®Google Scholar
• Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004;16(6):794-800
   Google Scholar
• Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64(8):2677-86
   PubMed Web of Science ®Google Scholar
• Johnson AE, Gordon C, Palmer RG, et al. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995;38(4):551-8
   Google Scholar
• Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15(5):308-18
   PubMed Web of Science ®Google Scholar
• Nightingale AL, Farmer RD, de Vries CS. Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Saf 2007;16(2):144-51
   Google Scholar
• Cohen A, Reynolds W, Franklin E, et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971;21:643-8
   Google Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25(11):1271-7
   PubMed Web of Science ®Google Scholar
• Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725
   PubMed Web of Science ®Google Scholar
• Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65(2):521-30
   PubMed Web of Science ®Google Scholar
• Font J, Ramos-Casals M, Cervera R, et al. Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 2001;94(1):19-26
   Google Scholar
• Waldman M, Appel GB. Update on the treatment of lupus nephritis. Kidney Int 2006;70(8):1403-12
   Google Scholar
• Sexton DJ, Reule S, Solid C, et al. ESRD From Lupus Nephritis in the United States, 1995-2010. Clin J Am Soc Nephrol 2015;10(2):251-9
   Google Scholar
• Mak A, Mok CC, Chu WP, et al. Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. Lupus 2007;16(1):28-34
   Google Scholar
• Seligman VA, Lum RF, Olson JL, et al. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med 2002;112(9):726-9
   Google Scholar
• Austin HA, Boumpas DT, Vaughan EM, et al. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994;45(2):544-50
   PubMed Web of Science ®Google Scholar
• Korbet SM, Schwartz MM, Evans J, et al. Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007;18(1):244-54
   Web of Science ®Google Scholar
• Barr RG, Seliger S, Appel GB, et al. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 2003;18(10):2039-46
   Google Scholar
• Contreras G, Lenz O, Pardo V, et al. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 2006;69(10):1846-51
   Google Scholar
• Dooley MA, Hogan S, Jennette C, et al. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular disease collaborative network. Kidney Int 1997;51(4):1188-95
   PubMedGoogle Scholar
• Isenberg D, Appel GB, Contreras G, et al. Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology 2010;49(1):128-40
   PubMed Web of Science ®Google Scholar
• Borchers AT, Naguwa SM, Shoenfeld Y, et al. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010;9(5):A277-87
   PubMed Web of Science ®Google Scholar
• Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore) 2004;83(1):1-17
   PubMed Web of Science ®Google Scholar
• Adler M, Chambers S, Edwards C, et al. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) 2006;45(9):1144-7
   Google Scholar
• Gibson KL, Gipson DS, Massengill SA, et al. Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. Clin J Am Soc Nephrol 2009;4(12):1962-7
   Google Scholar
• Austin HA, Boumpas DT, Vaughan EM, et al. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995;10(9):1620-8
   PubMed Web of Science ®Google Scholar
• Petri M, Perez-Gutthann S, Longenecker JC, et al. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91(4):345-53
   Web of Science ®Google Scholar
• De Castro WP, Morales JV, Wagner MB, et al. Hypertension and Afro-descendant ethnicity: a bad interaction for lupus nephritis treated with cyclophosphamide? Lupus 2007;16(9):724-30
   Google Scholar
• Cooper GS, Treadwell EL, St Clair EW, et al. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum 2007;57(6):993-9
   Web of Science ®Google Scholar
• Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004;350(10):971-80
   PubMed Web of Science ®Google Scholar
• Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 2006;15(3):148-55
   PubMed Web of Science ®Google Scholar
• Illei GG, Takada K, Parkin D, et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 2002;46(4):995-1002
   PubMed Web of Science ®Google Scholar
• Ramos PS, Brown EE, Kimberly RP, et al. Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol 2010;30(2):164-76
   PubMed Web of Science ®Google Scholar
• Block SR. A brief history of twins. Lupus 2006;15(2):61-4
   PubMed Web of Science ®Google Scholar
• Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992;35(3):311-18
   PubMed Web of Science ®Google Scholar
• Chung SA, Brown EE, Williams AH, et al. Lupus nephritis susceptibility Loci in women with systemic lupus erythematosus. J Am Soc Nephrol 2014;25(12):2859-70
   PubMed Web of Science ®Google Scholar
• Walport MJ, Black CM, Batchelor JR. The immunogenetics of SLE. Clin Rheum Dis 1982;8(1):3-21
   Google Scholar
• Niu Z, Zhang P, Tong Y. Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis. Int J Rheum Dis 2015;18(1):17-28
   Google Scholar
• Lu LJ, Wallace DJ, Ishimori ML, et al. Review: Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus 2010;19(2):119-29
   Google Scholar
• Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology (Oxford) 2013;52(12):2108-15
   PubMed Web of Science ®Google Scholar
• Schwartzman-Morris J, Putterman C. Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol 2012;2012:604892
   PubMedGoogle Scholar
• Shoenfeld Y, Tincani A, Gershwin ME. Sex gender and autoimmunity. J Autoimmun 2012;38(2-3):J71-3
   PubMed Web of Science ®Google Scholar
• Petri M. Sex hormones and systemic lupus erythematosus. Lupus 2008;17(5):412-15
   Web of Science ®Google Scholar
• Lahita RG. The importance of estrogens in systemic lupus erythematosus. Clin Immunol Immunopathol 1992;63(1):17-18
   Google Scholar
• Rider V, Abdou NI. Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 2001;1(6):1009-24
   PubMed Web of Science ®Google Scholar
• Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999;11(5):352-6
   PubMedGoogle Scholar
• Tan TC, Fang H, Magder LS, et al. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol 2012;39(4):759-69
   Google Scholar
• Stefanidou S, Benos A, Galanopoulou V, et al. Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male: female comparison. Lupus 2011;20(10):1090-4
   Google Scholar
• Jacobsen S, Petersen J, Ullman S, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998;17(6):468-77
   PubMed Web of Science ®Google Scholar
• Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis 2002;40(4):713-20
   PubMed Web of Science ®Google Scholar
• Julkunen H. Pregnancy and lupus nephritis. Scand J Urol Nephrol 2001;35(4):319-27
   PubMed Web of Science ®Google Scholar
• Tandon A, Ibañez D, Gladman DD, et al. The effect of pregnancy on lupus nephritis. Arthritis Rheum 2004;50(12):3941-6
   Web of Science ®Google Scholar
• Gladman DD, Tandon A, Ibañez D, et al. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol 2010;37(4):754-8
   PubMed Web of Science ®Google Scholar
• Kobkitcharoen M, Teerapornlertratt T, Chawanasuntorapoj R, et al. Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Siriraj Hospital. J Med Assoc Thai 2012;95(Suppl 2):S213-17
   Google Scholar
• Tang Z, Chen D, Yang S, et al. Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients. Rheumatol Int 2011;31(12):1625-9
   Google Scholar
• Papadimitraki ED, Isenberg DA. Childhood- and adult-onset lupus: an update of similarities and differences. Expert Rev Clin Immunol 2009;5(4):391-403
   PubMed Web of Science ®Google Scholar
• Ruggiero B, Vivarelli M, Gianviti A, et al. Lupus nephritis in children and adolescents: results of the Italian Collaborative Study. Nephrol Dial Transplant 2013;28(6):1487-96
   PubMed Web of Science ®Google Scholar
• Lee PY, Yeh KW, Yao TC, et al. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia. Lupus 2013;22(14):1534-40
   Google Scholar
• Amaral B, Murphy G, Ioannou Y, et al. A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus. Rheumatology (Oxford) 2014;53(6):1130-5
   Google Scholar
• Mannik M, Merrill CE, Stamps LD, et al. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 2003;30(7):1495-504
   PubMed Web of Science ®Google Scholar
• Rahman A, Manson JJ, Isenberg DA. Lupus Nephritis. In: Lewis E, Schwartz MM, Korbet SM, Chan DT, Editors. Autoantibodies and lupus nephritis. Oxford University Press, New York; 2011. p. 35-58
   Google Scholar
• Raz E, Brezis M, Rosenmann E, et al. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 1989;142(9):3076-82
   Google Scholar
• Ehrenstein MR, Katz DR, Griffiths MH, et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int 1995;48(3):705-11
   PubMed Web of Science ®Google Scholar
• Ng KP, Manson JJ, Rahman A, et al. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum 2006;55(6):900-4
   Google Scholar
• Furtado J, Isenberg DA. B cell elimination in systemic lupus erythematosus. Clin Immunol 2013;146(2):90-103
   Google Scholar
• Kallenberg C. Anti CIq antibodies. In: In Dubois lupus erythematosus and related symptoms. Elsevier, Philadelphia; 2013. p. 279-81
   Google Scholar
• Kalaaji M, Mortensen E, Jørgensen L, et al. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 2006;168(6):1779-92
   PubMed Web of Science ®Google Scholar
• Kalaaji M, Fenton KA, Mortensen ES, et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 2007;71(7):664-72
   PubMed Web of Science ®Google Scholar
• Faurschou M, Dreyer L, Kamper AL, et al. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res 2010;62(6):873-80
   Web of Science ®Google Scholar
• Croca SC, Rodrigues T, Isenberg DA. Assessment of a lupus nephritis cohort over a 30-year period. Rheumatology (Oxford) 2011;50(8):1424-30
   PubMed Web of Science ®Google Scholar
• Moroni G, Quaglini S, Gallelli B, et al. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transplant 2007;22(9):2531-9
   PubMed Web of Science ®Google Scholar
• Austin HA, Illei GG, Braun MJ, et al. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol 2009;20(4):901-11
   PubMed Web of Science ®Google Scholar
• Mok CC. Prognostic factors in lupus nephritis. Lupus 2005;14(1):39-44
   PubMed Web of Science ®Google Scholar
• James JA. Clinical perspectives on lupus genetics: advances and opportunities. Rheum Dis Clin North Am 2014;40(3):413-32
   Google Scholar
• Caster DJ, Korte EA, Nanda SK, et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. J Am Soc Nephrol 2013;24(11):1743-54
   Google Scholar
• Nanda SK, Venigalla RK, Ordureau A, et al. Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J Exp Med 2011;208(6):1215-28
   Google Scholar
• Adrianto I, Wang S, Wiley GB, et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum 2012;64(11):3695-705
   Google Scholar
• Li X, Ptacek TS, Brown EE, et al. Fcgamma receptors: structure, function and role as genetic risk factors in SLE. Genes Immun 2009;10(5):380-9
   Google Scholar
• Zidan HE, Sabbah NA, Hagrass HA, et al. Association of FcγRIIB and FcγRIIA R131H gene polymorphisms with renal involvement in Egyptian systemic lupus erythematosus patients. Mol Biol Rep 2014;41(2):733-9
   Google Scholar
• Alonso-Perez E, Suarez-Gestal M, Calaza M, et al. Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study. PLoS ONE 2012;7(9):e45356
   PubMed Web of Science ®Google Scholar
• Taylor KE, Remmers EF, Lee AT, et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008;4(5):e1000084
   PubMed Web of Science ®Google Scholar
• Bolin K, Sandling JK, Zickert A, et al. Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis. PLoS ONE 2013;8(12):e84450
   PubMed Web of Science ®Google Scholar
• Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010;329(5993):841-5
   PubMed Web of Science ®Google Scholar
• Freedman BI, Kopp JB, Langefeld CD, et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010;21(9):1422-6
   PubMed Web of Science ®Google Scholar
• Parsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013;369(23):2183-96
   PubMed Web of Science ®Google Scholar
• Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 2010;6(12):683-92
   PubMed Web of Science ®Google Scholar
• Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009;41(11):1234-7
   PubMed Web of Science ®Google Scholar
• Gateva V, Sandling JK, Hom G, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009;41(11):1228-33
   PubMed Web of Science ®Google Scholar